BioCentury
ARTICLE | Company News

Applied NeuroSolutions, Eli Lilly deal

December 4, 2006 8:00 AM UTC

LLY and APNS partnered to develop therapeutics to treat Alzheimer's disease (AD). LLY will have exclusive worldwide rights to APNS's IP related to the molecular neuropathology of AD as it pertains to ...